Compare Amphastar Pharmaceuticals Inc (AMPH) vs Elastic NV (ESTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Elastic NV — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.74 (market cap $826.08M), while Elastic NV trades at $60.64 (market cap $6.26B). The key difference: Elastic NV is far larger — about 7.6× Amphastar Pharmaceuticals Inc's market cap, and Elastic NV is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | ESTC | |
|---|---|---|
Market Cap | $826.08M | $6.26B |
Sector | Health | Technology |
52-Week High | $30.81 | $94.47 |
52-Week Low | $16.87 | $43.30 |
Enterprise Value | $1.22B | $5.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Elastic (ESTC) trades at $60.24, down 2.93% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $72.80. The company shows strong revenue growth, improving profitability into 2026, and consistent earnings beats, while recent news highlights leadership in security and observability markets.
The stock presents a growth opportunity with robust fundamentals and positive analyst sentiment, though risks include high valuation multiples, ongoing legal scrutiny, and competitive pressures in the software sector that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →
